Buprenorphine: new treatment of opioid addiction in primary care.
about
Update on the clinical use of buprenorphine: in opioid-related disordersImpact of research network participation on the adoption of buprenorphine for substance abuse treatment.Can you vaccinate against substance abuse?Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.Agonist-selective effects of opioid receptor ligands on cytosolic calcium concentration in rat striatal neuronsVaccines against drug abuse.Treatment of prescription opioid disorders in Canada: looking at the 'other epidemic'?Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats.Nicotine vaccines to treat tobacco dependence.Perioperative Pain Management for Patients on Chronic Buprenorphine: A Case Report.Primary care models for treating opioid use disorders: What actually works? A systematic reviewWillingness to receive intravenous buprenorphine treatment in opioid-dependent people refractory to oral opioid maintenance treatment: results from a community-based survey in France.Mise à jour sur l’utilisation clinique de la buprénorphine: pour les troubles reliés aux opioïdes.Lignes directrices canadiennes sur l’utilisation sécuritaire et efficace des opioïdes pour la douleur chronique non cancéreuse: Résumé clinique pour les médecins de famille. Partie 2: populations particulières.Buprenorphine-based opioid substitution therapy in India: A few observations, thoughts, and opinions
P2860
Q26829140-13F7B9F5-A0A0-480A-A099-7A33E89D01CAQ33776944-9D2A6A5F-D848-4589-B667-C0F4C929B281Q34132788-662F6D10-AA0D-4009-B454-E20ACFBB1E3FQ35490468-7A267F4A-59D6-4191-9B03-1B60F6C97058Q35548503-525E424E-568B-445F-ABC7-2D0202AB5789Q35875524-3BD32397-562A-41D1-9AEC-1E76CD6B8394Q35938624-79079794-4CF7-4A81-A2FE-E8EB5DBA3FC5Q36662425-645D49DC-6272-40B6-8798-A8D26D60CFAFQ37164033-8C79224A-D50B-44CF-A696-20E1F7B9FEF4Q37172159-4E886EEB-DC78-4971-82B8-CE2792CDC79FQ38056382-DCF064FE-0580-4D51-99D9-3DBD15671428Q42005602-B79AFD5B-97EF-4D82-A2BE-E4ACAA539BABQ42656779-021059E4-434C-46A7-B19B-C1AF3AABED74Q43142523-252E4172-AC5A-41C8-9D04-6EC6F495D22CQ45847009-42DC5989-7A6D-4CE2-A031-9DC65FE73919Q45871173-FDCAC828-2298-4FB4-9781-CED7740C0616Q58569574-0D649F6A-79A3-4F3C-8155-83ED6B2DCA63
P2860
Buprenorphine: new treatment of opioid addiction in primary care.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Buprenorphine: new treatment of opioid addiction in primary care.
@ast
Buprenorphine: new treatment of opioid addiction in primary care.
@en
Buprenorphine: new treatment of opioid addiction in primary care.
@nl
type
label
Buprenorphine: new treatment of opioid addiction in primary care.
@ast
Buprenorphine: new treatment of opioid addiction in primary care.
@en
Buprenorphine: new treatment of opioid addiction in primary care.
@nl
prefLabel
Buprenorphine: new treatment of opioid addiction in primary care.
@ast
Buprenorphine: new treatment of opioid addiction in primary care.
@en
Buprenorphine: new treatment of opioid addiction in primary care.
@nl
P2093
P2860
P1476
Buprenorphine: new treatment of opioid addiction in primary care
@en
P2093
Alice Ordean
Anita Srivastava
Meldon Kahan
Sharon Cirone
P2860
P304
P407
P577
2011-03-01T00:00:00Z